News Formal

Canada’s drug-pricing regulator brings rare allegation of excessive pricing against Horizon Pharma

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 92%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Patented Medicine Prices Review Board say that Horizon Pharma should dramatically slash the price of Procysbi and pay Ottawa as much as $3.15-million to account for the “excess” revenue the company has collected since it began selling the drug in Canada in September, 2017

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

You May want to mention that in everything else Trudeau gave away with the USMCA, he also agreed to higher drug prices in Canada so Trump’s friends would make more money win patent extensions...

Pharma companies are assholes. personalexperience

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in BUSİNESS

Business Business Latest News, Business Business Headlines